These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons. Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721 [TBL] [Abstract][Full Text] [Related]
53. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway. Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626 [TBL] [Abstract][Full Text] [Related]
54. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease. Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803 [TBL] [Abstract][Full Text] [Related]
55. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease. Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695 [TBL] [Abstract][Full Text] [Related]
57. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation. Xia XG; Schmidt N; Teismann P; Ferger B; Schulz JB J Neurochem; 2001 Oct; 79(1):63-70. PubMed ID: 11595758 [TBL] [Abstract][Full Text] [Related]
58. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Wilson JM; Levey AI; Bergeron C; Kalasinsky K; Ang L; Peretti F; Adams VI; Smialek J; Anderson WR; Shannak K; Deck J; Niznik HB; Kish SJ Ann Neurol; 1996 Sep; 40(3):428-39. PubMed ID: 8797532 [TBL] [Abstract][Full Text] [Related]
59. Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. I. Central nervous system. Schäfer MK; Eiden LE; Weihe E Neuroscience; 1998 May; 84(2):331-59. PubMed ID: 9539209 [TBL] [Abstract][Full Text] [Related]
60. Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. Hettinger BD; Lee A; Linden J; Rosin DL J Comp Neurol; 2001 Mar; 431(3):331-46. PubMed ID: 11170009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]